Board meeting on October 30, 2026 to consider and approve unaudited Q2 and H1 financial results
The Board of Directors is scheduled to meet on Friday, October 30, 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Friday, October 30, 2026
- Agenda
- unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026
- Trading Window
- closed till 48 hours after the results are declared
What the company has intimated
- A meeting of the Board of Directors is scheduled to be held on Friday, October 30, 2026.
- The agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
- The company has referred to these as the Financial Results in its letter to the National Stock Exchange of India Limited and BSE Limited.
Why it matters
This is the standard advance notice that listed companies give before a board meeting where results are taken on record. It tells the market the date on which the September quarter numbers are expected, and it starts the quiet period around that date. The intimation carries no revenue, profit, margin or volume figures, so nothing in it changes the picture of how the business performed in the quarter ended September 30, 2026.
Trading window
- The trading window for dealing in the company's securities will remain closed for all designated persons and their immediate relatives.
- The closure runs till 48 hours after the Financial Results are declared.
- This is in continuation of the company's earlier intimation dated September 25, 2026 regarding closure of the trading window.
- The restriction applies to designated persons and their immediate relatives, not to the general investing public.
What to watch for
- The unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026, once the Board considers and approves them.
- Any other business that comes up at the meeting, if the company later discloses it.
Reading this correctly
This update is a notice of a scheduled meeting and of a trading window restriction. It does not approve or declare any results yet, and it does not announce any dividend, fund raising or corporate action. The word 'scheduled' describes the meeting; approval is what the Board will consider on that date.
Also from Max Healthcare Institute
Max Healthcare to hold Q2 & H1 FY27 earnings call for investors and analysts on November 3, 2026
23 Oct 2026
Max Healthcare saw a short buildup in derivatives data amid continued focus on private hospital names
22 Oct 2026
Shareholders approve PRSU Scheme 2026, subsidiary grants and change in Main Objects Clause
19 Oct 2026
More numbers
- Trading window closure period after results declaration48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.